Effects of taking bedaquiline in the first three months
Bedaquiline (Bedaquiline) is a drug used to treat multidrug-resistant tuberculosis. Patients may see some therapeutic effects during the first three months after starting bedaquiline. Specific effects may vary depending on individual differences. Bedaquiline can inhibit the growth of tuberculosis bacteria and reduce the progression of the disease. In the first three months of using bedaquiline, patients may feel that their symptoms are relieved, such as cough, chest tightness, fever and other symptoms.
In the early stages of treatment, bedaquiline can reduce the number of tuberculosis bacteria, thereby showing better results on viral load tests. This means that patients may experience less severe TB infection. The therapeutic effects of bedaquiline can help patients reduce the burden of tuberculosis on their lives. Patients may gradually experience restored energy, increased appetite, and weight regain, thereby improving their quality of life. Currently, WHO does not recommend routine use of bedaquiline for more than 6 months. When using bedaquiline, you also need to pay attention to the occurrence of adverse reactions and side effects, such as nausea, vomiting, headache, joint pain, rash, dizziness, elevated transaminases, elevated blood amylase, diarrhea and QT interval prolongation.
The drug is sold in China under the name of daquiline fumarate tablets and has been included in the scope of medical insurance. The price of a common specification of 100mg*24 tablets per box may be around 10,000 yuan, which is relatively expensive. The price of the Russian version of Bedaquiline sold overseas, Specifications100mg*188 tablets per box, may be around RMB 15,000 (the price may fluctuate due to the exchange rate). The pharmaceutical ingredients of Bedaquiline sold domestically and abroad are basically the same. Currently, there are no generic bedaquiline drugs produced and marketed overseas. For specific prices and drug information of overseas drugs, please consult Yaode Medical Consultant.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)